Genus plc
Research Genus plc (GBE) on Bullrun: market cap EUR 1.75B, P/E 31.8, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGBE
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 1.75B
- P/E31.8
- Dividend yield1.4%
- Financial periodFY2025
- RevenueGBP 672.80M
- Revenue growth0.6%
- Free cash flowGBP 48.60M
Valuation Snapshot
latest market cap is EUR 1.75B; P/E is 31.8; dividend yield is 1.4%.
Peer valuation comparison
Latest P/E is 31.81x versus a Healthcare sector median of 24.46x (30.0% above).
Latest dividend yield is 1.42% versus a Healthcare sector median of 2.11% (32.7% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 672.80M | n/a | GBP 48.60M | n/a | 0.25 | GBP 48.00M | GBP 265.90M | GBP 475.60M |
| FY2024 | GBP 668.80M | GBP 19.30M | GBP 5.10M | 26.7% | 0.12 | GBP 42.50M | GBP 291.20M | GBP 517.80M |
| FY2023 | GBP 689.70M | GBP 2.40M | GBP 15.20M | 27.2% | 0.51 | GBP 36.30M | GBP 232.10M | GBP 544.50M |
| FY2022 | GBP 593.40M | GBP 31.80M | -GBP 31.10M | 24.9% | 0.62 | GBP 38.80M | GBP 223.80M | GBP 572.80M |
| FY2021 | GBP 593.40M | GBP 36.70M | -GBP 109.30M | 25.9% | 0.62 | GBP 46.00M | n/a | -GBP 1.50M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 1.75B | 31.8 | 1.4% | 0.38 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.38 EUR, yield 1.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.37 GBP |
| FY2024 | 0.37 GBP |
| FY2023 | 0.37 GBP |
| FY2022 | 0.37 GBP |
| FY2021 | 0.37 GBP |
About Genus plc
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Genus plc's market cap?
Genus plc's market capitalization is EUR 1.75B.
What is Genus plc's P/E ratio?
Genus plc's price-to-earnings (P/E) ratio is 31.8.
Does Genus plc pay a dividend?
Genus plc has a dividend yield of 1.4%.
What does Genus plc do?
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.